Patents
Patents for C07H 9 - Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical (1,178)
05/2008
05/27/2008US7378519 enantiomerically pure 1S,2S-tramadol hydrochloride by dissolving topiramate and tramadol hydrochloride; cooling; crystallization; filtration; separating the 1S,2S-tramadol hydrochloride from the mother liquor by chromatography or crystallization
05/07/2008EP1344109B1 Onium salts and the use therof as latent acids
05/07/2008CN101172989A Method for producing 5-O-acetyl-3-deoxidization-1,2-isopropylidene-alpha-D-tetrol xylose and midbody
05/06/2008US7368437 Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents
04/2008
04/30/2008CN100384862C Method of alpha-selective glycosylation
04/23/2008CN100383665C Onium salts and the use therof as latent acids
04/09/2008CN101157711A Compound having antineoplastic activity and uses thereof
04/01/2008US7351863 Method of fluorination
03/2008
03/26/2008CN100376591C Process for the preparation of anticonvulsant derivatives
02/2008
02/13/2008CN101121739A Hydrolysable tannin and application thereof
02/13/2008CN100368422C L-nucleic acid derivatives and processes for synthesis thereof
01/2008
01/09/2008EP1874788A1 Monosaccharide derivatives as anti-inflammatory and/or anti-cancer agents
12/2007
12/19/2007EP1326873A4 Combinatorial libraries of monosaccharides
12/12/2007EP1864992A2 Monosaccharide derivatives
10/2007
10/17/2007CN100343268C Beta -2'-or 3'-halonucleosides
10/10/2007EP1842855A2 Monosaccharide derivatives as anti-inflammatory and/or anti-cancer agents
10/03/2007CN101045740A Preparation method of topiramate
09/2007
09/27/2007WO2007108009A1 A process for purification of topiramate
09/19/2007EP1834957A1 Process for producing difructose dianhydride iii crystal
09/07/2007WO2007099388A1 An improved process for the manufacture of topiramate
09/05/2007EP1829884A1 Sugar donor
09/05/2007CN101029063A Method for selectivelly removing isopropyl from diisoprop ketal sugar derivative
08/2007
08/23/2007WO2007093769A1 Oligosaccharide biosynthesis inhibitors
08/21/2007CA2099589C Enantiomerically pure .beta.-d-(-)-dioxolane-nucleosides
07/2007
07/11/2007EP1805514A2 Immunoassays for topiramate
07/04/2007CN1990495A Method for quantitatively determining specific groups constituting heparins
06/2007
06/19/2007US7232900 making a glycosyl halide comprising reacting an O-silyl glycoside with an alpha , alpha -dihalomethyl alkyl ether in the presence of zinc chloride, zinc bromide or boron trifluoride; intermediate to synthesis of the immunostimulants
06/06/2007CN1974588A Method of fluorination
06/06/2007CN1974010A Catalyst for asymmetric (transfer) hydrogenation
04/2007
04/18/2007EP1775303A1 Topiramate and pharmaceutical compositions thereof
03/2007
03/28/2007CN1935822A Sucrose derivative and its preparing method, and method for synthesizing trichloro sucrose utilizing same
03/27/2007US7196209 Continuous process for the preparation of fructopyranose sulfamate derivatives
03/14/2007EP1178999B1 L-ribo-lna analogues
01/2007
01/17/2007EP1070068B2 Granulatimide derivatives for use in cancer treatment
01/02/2007US7157589 such as fructopyranose sulfamate derivatives formed by reacting diacetone fructose with sulfury diamide in presence of water; antiepileptic agents
01/02/2007US7157078 bait matrix comprising: a termiticide that causes death to 50-100% of termites within 24-84 days after the termites begin to ingest it; a cellulose containing material; and water; can be used in a bait station installed in the ground; kits may be used by consumers in their homes.
12/2006
12/13/2006CN1289515C Catalyst for asymmetric (transfer) hydrogenation
11/2006
11/21/2006US7138531 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
11/14/2006CA2239224C Topiramate immunoassay, as well as analogs and antibodies
10/2006
10/26/2006WO2006111783A1 Monosaccharide derivatives as anti-inflammatory and/or anti-cancer agents
10/24/2006US7125983 L-nucleic acid derivatives and process for the synthesis thereof
10/19/2006US20060234949 Adduct of topiramate and tramadol hydrochloride and uses thereof
10/11/2006CN1278681C Adduct of topiramate and tramadol hydrochloride and uses thereof
09/2006
09/19/2006US7109323 lyophilization of an aqueous mixture comprising a boronic add compound and a compound having at least two hydroxyl groups produces a stable composition that readily releases the boronic acid compound upon dissolution in aqueous media
09/19/2006US7109174 Anticonvulsant derivatives useful for preventing the development of type II diabetes mellitus and syndrome X
09/13/2006EP1325013B1 Catalyst for asymmetric (transfer) hydrogenation
09/06/2006CN1827214A Catalyst for asymmetric (transfer) hydrogenation
09/05/2006US7101908 Nontoxic treatment for infections from cytomegalovirus
08/2006
08/01/2006US7084125 Xylo-LNA analogues
07/2006
07/27/2006WO2005081904A3 Antimicrobial carbohydrates and methods of using same
07/26/2006EP1487812A4 Anomeric derivatives of monosaccharides
07/20/2006US20060160999 Reagents and methods for preparing lps antagonist b1287 and stereoisomers thereof
07/11/2006CA2325779C New derivatives of 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo[3,4-c]carbzole and 12,13 (pyranosyl)-furo[3,4-c]indol[2,3-a]carbazole, their preparation process and the pharmaceutical compositions therein
07/06/2006US20060148679 Glycosolated enkephalin agents
06/2006
06/28/2006CN1795199A Method of alpha-selective glycosylation
06/13/2006US7060725 Substituted sulfamate anticonvulsant derivatives
06/08/2006US20060122379 Method of alpha-selective glycosylation
06/01/2006WO2005092907B1 Monosaccharide derivatives as anti-cancer and anti-inflammatory agents
05/2006
05/30/2006US7053207 L-ribo-LNA analogues
05/17/2006EP0904275B1 Preparation of phosphorothioate oligomers
05/09/2006US7041650 Anticonvulsant derivative salts
05/03/2006EP1651342A2 Combinatorial synthesis on support
05/03/2006CN1254478C Derivatives of monosaccharides as well adhesion inhibitors
05/02/2006US7037899 Derivatives of 2-3-O- isopropylidene- alpha -L-xylo-2-hexulofuranosonic acid, useful for treating inflammatory and autoimmune diseases
04/2006
04/27/2006WO2005092907A3 Monosaccharide derivatives as anti-cancer and anti-inflammatory agents
04/18/2006US7030156 Devices and methods for eliminating termite colonies
04/06/2006WO2005100373A3 Monosaccharide derivatives as anti-cancer and anti-inflammatory agents
04/05/2006CN1756760A Process for the preparation of anticonvulsant derivatives
03/2006
03/22/2006EP1309324B1 Anticonvulsant derivatives useful for treating and preventing the development of type ii diabetes mellitus and syndrome x
03/16/2006US20060058373 Novel substituted sulfamate anticonvulsant derivatives
03/15/2006EP1558624B1 Continuous process for the preparation of fructopyranose sulfamate derivatives
03/08/2006CN1244588C C10 high carbon sugar and derivative, preparation method and use thereof
02/2006
02/28/2006US7005516 Derivatives of monosaccharides as cell adhesion inhibitors
02/28/2006US7005422 Derivatives of monosaccharides as cell adhesion inhibitors
02/23/2006US20060040874 Process for the preparation of topiramate
02/22/2006EP1627881A1 Process for the preparation of topiramate
02/21/2006CA2152486C Anticonvulsant sorbopyranose sulfamates
02/19/2006CA2505656A1 Process for the preparation of topiramate
02/16/2006WO2005062748A3 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae
02/15/2006EP1626053A2 Method of alpha-selective glycosylation
02/15/2006CN1735626A Novel anticonvulsant derivative salts
02/08/2006CN1732179A Continuous process for the preparation of fructopyranose sulfamate derivatives
02/08/2006CN1240706C Process for producing super critical extracting caterpillar fungus deoxynucleoside
01/2006
01/26/2006DE202005016250U1 Topiramat und pharmazeutische Formulierungen davon Topiramate and pharmaceutical formulations thereof
01/19/2006US20060014972 Method of fluorination
01/18/2006CN1237051C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
01/11/2006CN1720256A Method of fluorination
12/2005
12/22/2005US20050282742 Such as bortezomib, by freeze drying
12/15/2005US20050277599 3-O-ethyl-D-xylose; 2,4:3,5-di-O-benzylidene-D-xylose-dimethylacetal; effective at increasing glucose transport in a non-insulin dependent manner; diabetes
12/01/2005US20050267048 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae
11/2005
11/30/2005EP1599490A1 Process for the preparation of anticonvulsant derivatives of topiramate
11/29/2005US6969512 Devices and methods for eliminating termite colonies
11/23/2005EP1597265A2 Glycosolated enkephalin agents
11/15/2005US6964124 Devices and methods for eliminating termite colonies
11/09/2005EP1204669B1 Tricyclic monosaccharide derivatives useful in treating acute ischemia-induced neurodegeneration
11/03/2005US20050245746 for the solution or solid phase synthesis of carbohydrates; discovering novel drug
10/2005
10/27/2005WO2005100373A2 Monosaccharide derivatives as anti-cancer and anti-inflammatory agents
10/25/2005US6958319 Stability and longer shelf life; bortezomib N-(2-pyrazine)carbonyl-L-phenylalanine-L-leucine boronic acid
10/06/2005WO2005092907A2 Monosaccharide derivatives as anti-cancer and anti-inflammatory agents
10/05/2005EP1581545A1 Novel anticonvulsant derivative salts
1 2 3 4 5 6 7 8 9 10 11 12